Scott Lowe

• Howard Hughes Medical Institute

• Sloan Kettering Institute

  Chair, Cancer Biology & Genetics Program

• Sloan-kettering Inst Can Research

  Chair, cbg

Sources: mskcc.org, reporter.nih.gov

• National Cancer Institute

  R01, P-Selectin-Targeting Nanoparticles to Potentiate Cancer Immunotherapy, R01CA305504, 2026–2030, 28 Aug 2026

• National Institute on Aging

  RF1, Toward development of senolytic CAR T cells, RF1AG065396, 2020–2029, 20 Aug 2025

• National Institute on Aging

  U01, Impact of the aging niche on cancer phenotypes probed using mouse cancer models produced by somatic engineering., U01AG077921, 2021–2026, 18 Aug 2025

• National Institute on Aging

  R01, Toward development of senolytic CAR T cells, R01AG065396, 2020–2025, 21 Feb 2024

Sources: reporter.nih.gov